GB753166A
(en)
|
1953-05-22 |
1956-07-18 |
Miles Lab |
Improvements in or relating to substituted piperazines
|
US2993899A
(en)
|
1958-03-31 |
1961-07-25 |
Miles Lab |
Acetylenically unsaturated piperazine derivatives
|
US3309370A
(en)
|
1964-07-16 |
1967-03-14 |
Miles Lab |
Bicycloalkyl piperazine derivatives and process
|
GB1293565A
(en)
|
1969-05-03 |
1972-10-18 |
Aspro Nicholas Ltd |
Aminophthalazines and pharmaceutical compositions thereof
|
US3886161A
(en)
|
1970-12-14 |
1975-05-27 |
Sandoz Ag |
2-Piperazino-3-cyano-5-phenyl-pyridines
|
GB1345880A
(en)
|
1971-06-18 |
1974-02-06 |
Cepbepe |
Pyridazine derivatives
|
DE2516040C2
(de)
|
1974-06-10 |
1984-12-20 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
Benzimidazole, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
|
US3986161A
(en)
*
|
1975-04-07 |
1976-10-12 |
Sea-Scan, Inc. |
Underwater directional guidance apparatus
|
FR2306694A1
(fr)
|
1975-04-07 |
1976-11-05 |
Parcor |
Derives de la piperazine
|
GB1545094A
(en)
|
1976-12-14 |
1979-05-02 |
Gist Brocades Nv |
Piperazine derivatives
|
US4144346A
(en)
|
1977-01-31 |
1979-03-13 |
Janssen Pharmaceutica N.V. |
Novel 1-(1,3-dioxolan-2-ylmethyl)-1H-imidazoles
|
HU175471B
(hu)
|
1977-06-13 |
1980-08-28 |
Gyogyszerkutato Intezet |
Sposob poluchenija novykh proizvodnykh 3-skobka-1-pirazolil-skobka zakryta-piridazina
|
US4163849A
(en)
|
1978-03-17 |
1979-08-07 |
Merck & Co., Inc. |
Piperazinylpyrazines
|
DE2824764A1
(de)
|
1978-06-06 |
1979-12-20 |
Hoechst Ag |
Neue pyridylpiperazinderivate und verfahren zu ihrer herstellung
|
DE3160397D1
(en)
|
1980-02-22 |
1983-07-14 |
Tanabe Seiyaku Co |
Phenoxyalkane derivative and processes for preparing same
|
US4339579A
(en)
|
1980-12-29 |
1982-07-13 |
American Home Products Corporation |
2,6-Bis-(pyrrolopyrazinyl)pyrazines
|
US4616014A
(en)
|
1981-10-22 |
1986-10-07 |
Fujisawa Pharmaceutical Co., Ltd. |
Triazine derivatives, and pharmaceutical compositions comprising the same
|
US5001125A
(en)
|
1984-03-26 |
1991-03-19 |
Janssen Pharmaceutica N.V. |
Anti-virally active pyridazinamines
|
FR2573075B1
(fr)
|
1984-09-14 |
1987-03-20 |
Innothera Lab Sa |
Nouvelles (pyridyl-2)-1 piperazines, leur procede de preparation et leur application en therapeutique
|
EP0204003A4
(en)
|
1984-11-27 |
1987-06-03 |
Dainippon Pharmaceutical Co |
2- (1-PIPERAZINYL) -4-SUBSTITUTED PHENYLQUINOLINE SCRUBBINGS.
|
PH25772A
(en)
|
1985-08-30 |
1991-10-18 |
Novo Industri As |
Insulin analogues, process for their preparation
|
DK111387A
(da)
|
1986-03-05 |
1987-09-06 |
Otsuka Pharma Co Ltd |
Carbostyrilderivater og salte deraf, laegemiddel indeholdende saadanne derivater samt fremgangsmaade til fremstilling af derivaterne
|
DE3609596A1
(de)
|
1986-03-21 |
1987-10-01 |
Hoechst Ag |
2-azolylmethyl-2-aryl-1,3-dioxolane und deren salze, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung
|
MY104343A
(en)
|
1987-11-23 |
1994-03-31 |
Janssen Pharmaceutica Nv |
Novel pyridizinamine deravatives
|
DE3803860A1
(de)
|
1988-02-09 |
1989-08-17 |
Basf Ag |
N,n'-disubstituierte piperazine
|
DE3837825A1
(de)
|
1988-11-08 |
1990-05-10 |
Hoechst Ag |
Neue insulinderivate, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
|
DK0385237T3
(da)
|
1989-03-03 |
1994-07-25 |
Dainippon Pharmaceutical Co |
2-(1-Piperazinyl)-4-phenylcycloalkanopyridinderivater, fremgangsmåde til fremstilling deraf og farmaceutisk præparat indeholdende dem
|
GB9012316D0
(en)
|
1990-06-01 |
1990-07-18 |
Wellcome Found |
Pharmacologically active cns compounds
|
AU5704594A
(en)
|
1992-12-18 |
1994-07-19 |
Wellcome Foundation Limited, The |
Pyrimidine, pyridine, pteridinone and indazole derivatives as enzyme inhibitors
|
WO1994022846A1
(en)
|
1993-03-30 |
1994-10-13 |
Pfizer Inc. |
Compounds enhancing antitumor activity of other cytotoxic agents
|
DK0705275T3
(da)
|
1993-06-21 |
1999-09-20 |
Novo Nordisk As |
AspB28-insulin-krystaller
|
BR9407508A
(pt)
|
1993-09-17 |
1997-01-07 |
Novo Nordisk As |
Derivado de insulina composição farmaceutica e processo para o tratamento de diabete em um paciente com necessidade deste tratamento
|
IL111730A
(en)
|
1993-11-29 |
1998-12-06 |
Fujisawa Pharmaceutical Co |
Piperazine derivatives, processes for their preparation and pharmaceutical preparations containing them
|
US5504188A
(en)
|
1994-06-16 |
1996-04-02 |
Eli Lilly And Company |
Preparation of stable zinc insulin analog crystals
|
AU6318896A
(en)
|
1995-07-06 |
1997-02-05 |
Japan Tobacco Inc. |
Benzamidoxime derivatives and medicinal use thereof
|
US6130217A
(en)
|
1995-09-20 |
2000-10-10 |
Pfizer Inc |
Compounds enhancing antitumor activity of other cytotoxic agents
|
EP0863897B1
(fr)
|
1995-11-09 |
1999-06-16 |
Synthelabo |
Derives de 5-phenyl-3-(piperidin-4-yl)-1,3,4-oxadiazol-2(3h)-one, utiles comme ligands des recepteurs 5-ht4 ou h3
|
HUP9902056A3
(en)
|
1996-01-17 |
2002-02-28 |
Novo Nordisk As |
Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use
|
EP0923580A1
(en)
|
1996-07-26 |
1999-06-23 |
Dr. Reddy's Research Foundation |
Thiazolidinedione compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions thereof
|
PL192359B1
(pl)
|
1996-08-30 |
2006-10-31 |
Novo Nordisk As |
Pochodna GLP-1(7-37) lub analogu GLP-1(7-37), środek farmaceutyczny oraz zastosowanie pochodnej GLP-1(7-37) lub analogu GLP-1(7-37)
|
DZ2376A1
(fr)
|
1996-12-19 |
2002-12-28 |
Smithkline Beecham Plc |
Dérivés de sulfonamides nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant.
|
DK0958296T3
(da)
|
1996-12-31 |
2003-08-18 |
Reddys Lab Ltd Dr |
Heterocykliske forbindelser, fremgangsmåde til deres fremstilling og farmaceutiske præparater, der indeholder dem, og deres anvendelse i behandlingen af diabetes og beslægtede sygdomme
|
WO1997041119A1
(en)
|
1997-05-02 |
1997-11-06 |
Dr. Reddy's Research Foundation |
Novel antidiabetic compounds having hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
|
US6613942B1
(en)
|
1997-07-01 |
2003-09-02 |
Novo Nordisk A/S |
Glucagon antagonists/inverse agonists
|
JP2003514508A
(ja)
|
1997-07-01 |
2003-04-15 |
ノボ ノルディスク アクティーゼルスカブ |
グルカゴン拮抗剤/逆作用剤
|
EP1000066A1
(en)
|
1997-07-16 |
2000-05-17 |
Novo Nordisk A/S |
Fused 1,2,4-thiadiazine derivatives, their preparation and use
|
DE69839887D1
(de)
|
1997-10-02 |
2008-09-25 |
Eisai R&D Man Co Ltd |
Kondensierte pyridinderivate
|
US6440961B1
(en)
|
1997-10-27 |
2002-08-27 |
Dr. Reddy's Research Foundation |
Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
|
WO1999019313A1
(en)
|
1997-10-27 |
1999-04-22 |
Dr. Reddy's Research Foundation |
Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them
|
HUP0004512A3
(en)
|
1997-10-27 |
2003-01-28 |
Agouron Pharmaceuticals Inc La |
4-aminothiazole derivatives, their preparation and their use as inhibitors of cyclin-dependent kinases
|
JP4391597B2
(ja)
|
1997-12-02 |
2009-12-24 |
ドクター・レディーズ・ラボラトリーズ・リミテッド |
抗糖尿病性、低脂質性及び抗高血圧性を有するチアゾリンジオンとオキサゾリジンジオン誘導体
|
GB9803536D0
(en)
|
1998-02-19 |
1998-04-15 |
Black James Foundation |
Histamine H,receptor ligands
|
EP0978512A1
(en)
|
1998-07-29 |
2000-02-09 |
Societe Civile Bioprojet |
Non-imidazole aryloxy (or arylthio) alkylamines as histamine H3-receptor antagonists and their therapeutic applications
|
WO2000023451A1
(en)
|
1998-10-21 |
2000-04-27 |
Novo Nordisk A/S |
New compounds, their preparation and use
|
EP1123269A1
(en)
|
1998-10-21 |
2001-08-16 |
Novo Nordisk A/S |
New compounds, their preparation and use
|
JP2002527516A
(ja)
|
1998-10-21 |
2002-08-27 |
ノボ ノルディスク アクティーゼルスカブ |
新規化合物、それらの製造及び使用
|
WO2000023425A1
(en)
|
1998-10-21 |
2000-04-27 |
Novo Nordisk A/S |
New compounds, their preparation and use
|
AU6325699A
(en)
|
1998-10-21 |
2000-05-08 |
Dr. Reddy's Research Foundation |
New compounds, their preparation and use
|
WO2000023415A1
(en)
|
1998-10-21 |
2000-04-27 |
Novo Nordisk A/S |
New compounds, their preparation and use
|
AU1649900A
(en)
|
1998-12-18 |
2000-07-12 |
Novo Nordisk A/S |
Fused 1,2,4-thiadiazine derivatives, their preparation and use
|
WO2000041121A1
(en)
|
1999-01-07 |
2000-07-13 |
Ccrewards.Com |
Method and arrangement for issuance and management of digital coupons and sales offers
|
JP2002534512A
(ja)
|
1999-01-15 |
2002-10-15 |
ノボ ノルディスク アクティーゼルスカブ |
非ペプチドglp−1アゴニスト
|
BR0010683A
(pt)
|
1999-04-16 |
2003-07-01 |
Reddy Research Foundation |
Formas polimórficas de um agente antidiabético: processo para seu preparo e composições farmacêuticas contendo o mesmo
|
AU2953699A
(en)
|
1999-04-16 |
2000-11-02 |
Dr. Reddy's Research Foundation |
Novel polymorphic forms of an antidiabetic agent: process for their preparation and a pharmaceutical composition containing them
|
WO2000063189A1
(en)
|
1999-04-16 |
2000-10-26 |
Novo Nordisk A/S |
Crystalline r- guanidines, arginine or (l) -arginine (2s) -2- ethoxy -3-{4- [2-(10h -phenoxazin -10-yl)ethoxy]phenyl}propanoate
|
JP2002542246A
(ja)
|
1999-04-20 |
2002-12-10 |
ノボ ノルディスク アクティーゼルスカブ |
新規な化合物、それらの製造及び使用
|
AU3958200A
(en)
|
1999-04-20 |
2000-11-02 |
Novo Nordisk A/S |
New compounds, their preparation and use
|
JP2002542237A
(ja)
|
1999-04-20 |
2002-12-10 |
ノボ ノルディスク アクティーゼルスカブ |
新規な化合物、それらの製造及び使用
|
BR0009864A
(pt)
|
1999-04-20 |
2002-01-08 |
Novo Nordisk As |
Composto, composição farmacêutica, métodos para o tratamento de doenças, para o tratamento e/ou prevenção de condições mediadas pelos receptores nucleares e para o tratamento e/ou prevenção de diabete e/ou obesidade, e, uso de um composto
|
WO2000066578A1
(en)
|
1999-04-30 |
2000-11-09 |
Pfizer Products Inc. |
Compounds for the treatment of obesity
|
GB9926303D0
(en)
|
1999-11-05 |
2000-01-12 |
Smithkline Beecham Plc |
Novel compounds
|
GB9926302D0
(en)
|
1999-11-05 |
2000-01-12 |
Smithkline Beecham Plc |
Novel compounds
|
US6602872B1
(en)
|
1999-12-13 |
2003-08-05 |
Merck & Co., Inc. |
Substituted pyridazines having cytokine inhibitory activity
|
FR2802206B1
(fr)
|
1999-12-14 |
2005-04-22 |
Sod Conseils Rech Applic |
Derives de 4-aminopiperidine et leur utilisation en tant que medicament
|
DE60022386T2
(de)
|
1999-12-16 |
2006-06-22 |
Schering Corp. |
Substituierte imidazole als neuropeptide y y5 rezeptor antagonisten
|
FI20000480A0
(fi)
|
2000-03-01 |
2000-03-01 |
Orion Yhtymae Oyj |
Kinoliini- ja naftaleenijohdannaisia alfa-2 antagonisteina
|
WO2001066534A2
(en)
|
2000-03-09 |
2001-09-13 |
Abbott Laboratories |
Cyclic and bicyclic diamino histamine-3 receptor antagonists
|
AU2001251083A1
(en)
|
2000-03-31 |
2001-10-15 |
Ortho-Mcneil Pharmaceutical, Inc. |
Method for using 2-aryloxyalkylaminobenzoxazoles and 2-aryloxyalkylaminobenzothiazoles as h3 antagonists
|
EP1268478B1
(en)
|
2000-03-31 |
2007-05-02 |
Ortho-McNeil Pharmaceutical, Inc. |
Phenyl-substituted imidazopyridines
|
DE60101906T2
(de)
|
2000-03-31 |
2004-11-04 |
Ortho-Mcneil Pharmaceutical, Inc. |
Phenyl-substituierte indolizinderivate und deren verwendung als histamin h3 liganden
|
AU2001249672A1
(en)
|
2000-03-31 |
2001-10-15 |
Ortho-Mcneil Pharmaceutical, Inc. |
Method for using 2- or 3-aryl substituted imidazo(1,2-a) pyridines as h3 antagonists
|
EP1268421B1
(en)
|
2000-03-31 |
2009-05-06 |
Ortho-McNeil Pharmaceutical, Inc. |
Phenyl-substituted indoles as histamine h3-receptor antagonists
|
AU2001281121B2
(en)
|
2000-08-08 |
2007-08-23 |
Ortho-Mcneil Pharmaceutical, Inc. |
Non-imidazole aryloxypiperidines as H3 receptor ligands
|
US6316475B1
(en)
|
2000-11-17 |
2001-11-13 |
Abbott Laboratories |
Aminoalkoxybiphenylcarboxamides as histamine-3 receptor ligands and their therapeutic applications
|
WO2002060392A2
(en)
|
2001-01-31 |
2002-08-08 |
Synaptic Pharmaceutical Corporation |
Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
|
US20030073672A1
(en)
|
2001-09-05 |
2003-04-17 |
Breitenbucher J. Guy |
Method for treating allergies using substituted pyrazoles
|
US20030236259A1
(en)
|
2002-02-05 |
2003-12-25 |
Rolf Hohlweg |
Novel aryl- and heteroarylpiperazines
|
EP1474401A2
(en)
*
|
2002-02-05 |
2004-11-10 |
Novo Nordisk A/S |
Novel aryl- and heteroarylpiperazines
|
US6864261B2
(en)
|
2002-05-02 |
2005-03-08 |
Euro-Celtique S.A. |
Therapeutic agents useful for treating pain
|
SE0201544D0
(sv)
|
2002-05-17 |
2002-05-17 |
Biovitrum Ab |
Novel compounds and thier use
|
US6906060B2
(en)
|
2002-06-06 |
2005-06-14 |
Novo Nordisk A/S |
Substituted hexahydropyrrolo[1,2-a]pyrazines, octahydropyrido[1,2-a]-pyrazines and decahydropyrazino[1,2-a]azepines
|
ES2283768T3
(es)
|
2002-06-06 |
2007-11-01 |
Novo Nordisk A/S |
Hexahidropirrolo(1,2-a)piracinas, octahidropirido(1,2-a)piracinas y decahidropiracino(1,2-a)acepinas sustituidas.
|
US7332508B2
(en)
|
2002-12-18 |
2008-02-19 |
Novo Nordisk A/S |
Substituted homopiperidine, piperidine or pyrrolidine derivatives
|
BRPI0413048A
(pt)
|
2003-07-29 |
2006-10-17 |
Novo Nordisk As |
composto, composição farmacêutica, uso de um composto, e, método para o tratamento de distúrbios ou doenças relacionados com o receptor h3 da histamina
|
JP4765627B2
(ja)
|
2003-09-22 |
2011-09-07 |
Msd株式会社 |
新規ピペリジン誘導体
|
FR2864080B1
(fr)
|
2003-12-23 |
2006-02-03 |
Sanofi Synthelabo |
Derives de 1-piperazine-et-1-homopiperazine-carboxylates, leur preparation et leur application en therapeutique
|
EP1737843B1
(en)
|
2004-04-09 |
2011-02-23 |
Merck Sharp & Dohme Corp. |
Inhibitors of akt activity
|
AU2005260102A1
(en)
|
2004-05-08 |
2006-01-12 |
Novartis International Pharmaceutical Ltd. |
3-aryl-5,6-disubstituted pyridazines
|
WO2006050389A2
(en)
|
2004-11-02 |
2006-05-11 |
Northwestern University |
Pyridazine compounds, compositions and methods
|
EP1824829B1
(en)
|
2004-12-03 |
2010-05-05 |
F. Hoffmann-Roche AG |
3-substituted pyridine derivatives as h3 antagonists
|
GB0501146D0
(en)
|
2005-01-20 |
2005-02-23 |
Astrazeneca Ab |
Novel benzamide derivatives
|
JP2008536950A
(ja)
|
2005-04-18 |
2008-09-11 |
ニューロジェン・コーポレーション |
置換ヘテロアリールのcb1拮抗薬
|
FR2885615B1
(fr)
|
2005-05-12 |
2007-06-22 |
Servier Lab |
Nouveaux derives de phenylpyridinylpiperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
FR2885616B1
(fr)
|
2005-05-12 |
2007-06-22 |
Servier Lab |
Nouveaux derives de phenylpyridinylpiperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
ES2375929T3
(es)
|
2005-07-04 |
2012-03-07 |
High Point Pharmaceuticals, Llc |
Antagonistas del receptor histamina h3.
|
BRPI0613403A2
(pt)
|
2005-07-15 |
2009-02-10 |
Amr Technology Inc |
tetrahidrobenzodiazepinas aril- e heteroarila-substituÍdas e uso das mesmas para bloquear a recaptaÇço de norepinefrina, dopamina e serotonina
|
WO2007016496A2
(en)
|
2005-08-02 |
2007-02-08 |
Neurogen Corporation |
Dipiperazinyl ketones and related analogues
|
NZ570524A
(en)
|
2006-03-28 |
2011-08-26 |
High Point Pharmaceuticals Llc |
Benzothiazoles having histamine H3 receptor activity
|
EP2038256A1
(en)
|
2006-05-23 |
2009-03-25 |
TransTech Pharma, Inc |
6- (4-cyclopropylpiperazin-1-yl) -2 ' -methyl- [3, 4 ']-bipyridine and its use as a medicament
|
ATE538116T1
(de)
|
2006-05-29 |
2012-01-15 |
High Point Pharmaceuticals Llc |
3-(1,3-benyodioxol-5-yl)-6- (4- cyclopropylpiperazin-1-yl)-pyridazin, dessen salze und solvate und dessen verwendung als histamin-h3-rezeptorantagonist
|
EP2014656A3
(en)
|
2007-06-11 |
2011-08-24 |
High Point Pharmaceuticals, LLC |
New heteocyclic h3 antagonists
|